Non-surgical Spinal Decompression Therapy and Outcomes
Launched by UNIVERSITY OF SOUTH FLORIDA · Jul 26, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new treatment called non-surgical spinal decompression therapy to help people with chronic low back pain (LBP). LBP is a common issue that can make it hard to do everyday activities and enjoy life. Many current treatments for LBP can have serious side effects or may not work well, and some people may even rely on painkillers. This trial aims to see if this non-invasive therapy can effectively relieve pain without the risks associated with surgery or medications.
To participate in the trial, individuals must be between the ages of 65 and 74 and have had chronic low back pain for at least three months due to certain back problems. However, people with serious spinal conditions, other chronic pain issues, or those who are pregnant or have had back surgery cannot take part. Participants will undergo testing over 12 weeks, including MRI scans, to help researchers understand how well this new therapy works. If you or someone you know struggles with chronic back pain, this trial may offer a promising alternative treatment option.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Diagnosis of chronic LBP for a minimum of 3 months caused by pathological intervertebral disc, degenerative disc disease, posterior facet syndrome, and/or sciatica.
- Exclusion Criteria:
- • Known serious spinal pathology (e.g., vertebral fracture, tumor, osteoporosis)
- • Evidence of central nervous system involvement of pain
- • Other chronic pain conditions
- • Pregnancy
- • Spinal fusion
- • Inability to comply with treatment schedule
- • Inability to complete MRIs (e.g., claustrophobia, pacemaker, ferromagnetic implants)
About University Of South Florida
The University of South Florida (USF) is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong commitment to improving patient outcomes, USF leverages its diverse faculty expertise and state-of-the-art facilities to conduct rigorous and ethically sound research. The university fosters collaboration across disciplines, engaging in partnerships that enhance the translation of scientific discoveries into effective therapeutic interventions. USF's clinical trial programs are designed to address pressing health challenges and contribute to the body of knowledge in various medical fields, ultimately aiming to benefit communities and improve public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tampa, Florida, United States
Tampa, Florida, United States
Stanford, California, United States
Patients applied
Trial Officials
Nathan D Schilaty, DC, PhD
Principal Investigator
University of South Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported